Skip to main content
Fig. 9 | BMC Pulmonary Medicine

Fig. 9

From: Strategies for understanding the role of cellular heterogeneity in the pathogenesis of lung cancer: a cell model for chronic exposure to cigarette smoke extract

Fig. 9

The stemness gene expression levels of the 16HBE-B and 16HBE-S cells of different generations. A The relative mRNA level of SOX4 expression in the 16HBE-B control and CSE groups. B The relative mRNA level of SOX4 expression in the 16HBE-S control and CSE groups. C The relative mRNA level of SOX2 expression in the 16HBE-B control and CSE groups. D The relative mRNA level of SOX2 expression in the 16HBE-S control and CSE groups. E The relative mRNA level of SOX9 expression in the 16HBE-B control and CSE groups. F The relative mRNA level of SOX9 expression in the 16HBE-S control and CSE groups. G The relative mRNA level of NANOG expression in the 16HBE-B control and CSE groups. H The relative mRNA level of NANOG expression in the 16HBE-S control and CSE groups. I The relative mRNA level of KRT5 expression in the 16HBE-B control and CSE groups. J The relative mRNA level of KRT5 expression in the 16HBE-S control and CSE groups. K The relative mRNA level of KRT14 expression in the 16HBE-B control and CSE groups. L The relative mRNA level of KRT14 expression in the 16HBE-S control and CSE groups. M The relative mRNA level of PD-L1 expression in the 16HBE-B control and CSE groups. N The relative mRNA level of PD-L1 expression in the 16HBE-S control and CSE groups. *P ≤ 0.05, n = 3, **P ≤ 0.01, n = 3, versus P1 Group

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us